M 27 (Methylphenidate Hydrochloride Extended-Release 27 mg)
Pill with imprint M 27 is Gray, Capsule-shape and has been identified as Methylphenidate hydrochloride extended-release 27 mg. It is supplied by Mallinckrodt, Inc..
Methylphenidate is used in the treatment of adhd; narcolepsy; depression; fatigue; obesity (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 27 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for M 27
Methylphenidate hydrochloride extended-release
- Imprint:
- M 27
- Strength:
- 27 mg
- Color:
- Gray
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Mallinckrodt, Inc.
- National Drug Code (NDC):
- 00406-0127
More about methylphenidate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 673 Reviews – Add your own review/rating
- Drug class: CNS stimulants
Consumer resources
- Methylphenidate
- Methylphenidate transdermal
- Methylphenidate Chewable Tablets
- Methylphenidate Controlled-Release Tablets
- Methylphenidate Extended-Release Chewable Tablets
- ... +8 more
Other brands: Ritalin, Concerta, Metadate CD, Quillivant XR, ... +9 more
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
